Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Hypertension. 2019 Jul 1;74(2):276–284. doi: 10.1161/HYPERTENSIONAHA.119.13073

Table 4.

Association between 18-month change in cardiac MRI measures and incidence of the primary composite cardiovascular outcome following the 18-month study visit

HR (95% CI) p-value
Measure per 1 SD decrease
Change in LV Mass (g) 1.39(0.95, 2.03) 0.094
Change in LV End Diastolic Volume (ml) 0.84(0.52, 1.37) 0.486
Change in LV Mass/LV End Diastolic Volume 1.15(0.71, 1.87) 0.561
Change in LV End Systolic Volume (ml) 0.91(0.57, 1.47) 0.707
Change in Stroke Volume (ml) 0.81(0.50, 1.31) 0.391
Change in Cardiac Output (ml/min) 0.72(0.45, 1.16) 0.652
Change in LV Ejection Fraction (%) 0.82(0.50, 1.36) 0.450
Change in Myocardial native T1 (milliseconds) 0.88(0.51, 1.52) 0.652

HR indicates Hazard Ratio based on Cox proportional hazards regression adjusting for baseline value; LV, Left Ventricular; SD, Standard Deviation. Primary cardiovascular composite endpoint includes myocardial infarction, acute coronary syndrome, stroke, heart failure, or death from cardiovascular causes.